What is Equinosis?
Equinosis operates at the intersection of advanced inertial sensor technology and equine veterinary care. The company is best known for its flagship diagnostic platform, the Equinosis Q with Lameness Locator, which provides practitioners with objective, data-driven insights into equine movement. By utilizing non-invasive sensors and proprietary algorithms, the system detects subtle lameness metrics that frequently escape human observation. This evidence-based approach has established Equinosis as a trusted partner for leading veterinary universities and private practices worldwide, effectively digitizing the diagnostic process and improving clinical outcomes for equine patients.
How much funding has Equinosis raised?
Equinosis has raised a total of $83K across 1 funding round:
Debt
$83K
Debt (2021): $83K with participation from PPP
Key Investors in Equinosis
PPP
Public-Private Partnership
What's next for Equinosis?
With the recent infusion of capital, Equinosis is poised to accelerate its strategic roadmap, focusing on the refinement of its diagnostic algorithms and the expansion of its global distribution network. The company is expected to prioritize the integration of its sensor data into broader electronic health record systems, enhancing the interoperability of its diagnostic tools. As the demand for objective, real-time health monitoring in the equine industry continues to rise, Equinosis is strategically positioned to leverage its technological moat to capture additional market share. Future initiatives will likely include the development of next-generation hardware and the expansion of its data analytics capabilities to support long-term equine wellness monitoring.
See full Equinosis company page
